EULAR Updates Behçet’s Syndrome Recommendations - Summary - MDSpire
From the Journals
Clinical Guidelines

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Share

The European Alliance of Associations for Rheumatology has updated its recommendations for managing Behçet’s syndrome, emphasizing the need for earlier biologic intervention for patients with eye, vascular, and nervous system involvement. The guidelines, developed by a 29-member task force, include five overarching principles and 12 recommendations on various organ involvements. Evidence from 81 studies formed the basis for this update, which aims to reduce irreversible organ damage, improve quality of life, and adopt a personalized treatment approach.

Original Source(s)

EULAR Updates Behçet’s Syndrome Recommendations

  • by Kathryn Wighton

  • April 1, 2026

Related Content

RA App Overestimates Active Disease

Self-reported joint counts showed modest agreement with physician assessments and tended to overestimate active disease in a community-based study

Low DLCO/SB Linked to Faster SSc Progression

Lower gas transfer at baseline was associated with higher unadjusted progression rates and shorter time to transition, though multivariable analysis did not identify independent predictors

TENS Added to Physical Therapy Lowers Fibromyalgia Pain

Adjunctive transcutaneous electrical nerve stimulation improves movement-evoked pain and fatigue in pragmatic trial